Better Antibiotic Trials Sought as Congress Weighs Funding Bill

The FDA should implement more rigorous clinical trial standards for new antibiotics, doctors and infectious disease policy analysts say, as Congress considers legislation to fund antimicrobial development.

The Pioneering Antimicrobial Subscriptions to End Upsurging Resistance, or PASTEUR, Act would allocate $6 billion for the government to pay developers upfront for access to new antibiotics to treat drug-resistant infections. Lawmakers behind the bill, which is being pursued as an amendment to the National Defense Authorization Act, say it would help bring a wave of new treatments to patients and offer a much-needed response to the growth of infections resistant to the ...